Strategic partner for the Québec health system
|
|
- Emmeline Sanders
- 5 years ago
- Views:
Transcription
1 BLOOD PRODUCTS STABLE PRODUCTS STEM CELLS Strategic partner for the Québec health system HUMAN TISSUES MOTHER S MILK CORPORATE PRESENTATION
2 MISSION To efficiently meet the needs of the Québec population for quality blood and other biological products of human origin. VISION To become a strategic partner for the Québec health system.
3 BLOOD AND BIOLOGICAL PRODUCTS OF HUMAN ORIGIN SYSTEM IN QUÉBEC MINISTER OF HEALTH AND SOCIAL SERVICES HEALTH CANADA BIOVIGILANCE COMMITTEE HÉMA-QUÉBEC HOSPITALS DONORS RECIPIENTS 3
4 FROM SUPPLIER OF BLOOD PRODUCTS TO EXPERT First cases of HIV transmitted through blood Contaminated blood scandal Adoption of the Act Respecting Héma-Québec Héma-Québec starts its operations Creation of the unrelated bone marrow donor registry in Canada Release of the Gélineau Committee report The Red Cross announces its withdrawal from the Canadian blood program as of September 1998 Krever Commission report tabled 4
5 IN BIOLOGICAL PRODUCTS OF HUMAN ORIGIN Creation of the Québec Public Cord Blood Bank Creation of the no-fault compensation scheme Creation of the Québec Public Mothers Milk Bank Acquisition of the assets of the Centre de conservation de tissus humains du Québec Opening of the first GLOBULE Blood Donor Centre Operational start-up of the first GLOBULE Mobile Blood Donation Unit Revision of the Act Respecting Héma Québec: extended mandate to biological products of human origin Opening of the Mobile Blood Drive Regional Centre Opening of the first PLASMAVIE Plasma Donor Lounge Héma-Québec assumes full management of the Stem Cell Donor Registry in Québec 5
6 HÉMA-QUÉBEC IS... CLOSE TO 225,000 BLOOD, STEM CELL, MOTHER S MILK AND HUMAN TISSUE DONORS A great team dedicated to the gift of life 1,347 OF EMPLOYEES THOUSANDS VOLUNTEERS ANNUAL REVENUE $450M 6
7 PERMANENT PRESENCE THROUGHOUT QUÉBEC Facility GLOBULE Mobile Blood Drive Regional Centre PLASMAVIE PLASMAVIE with a blood donation area Drop-off point for mother s milk NEW Saguenay (June 2018) NEW Québec Arrondissement Sainte-Foy Saint-Laurent Quartier Lebourgneuf (June 2018) Trois-Rivières NEW (Fall 2018) Montréal Gatineau Laval Brossard Sherbrooke NEW (April 2018) 7
8 BLOOD PRODUCTS Justine makes her first blood donation. 8
9 COLLECTIVE BLOOD SUPPLY 304,920 BLOOD PRODUCTS DELIVERED 173,244 DONORS PER YEAR (all types of donations) generated over 357,039 visits to collection sites 2,416 MOBILE BLOOD DRIVES organized each year (including blood drives in mobile units) COLLECTION METHODS MOBILE BLOOD DRIVES CENTRES MOBILE UNITS 20% 7% 73% FROM DONATION TO DISTRIBUTION DELIVERY Products are delivered to hospitals. The blood components used vary depending on the patient. STORAGE Compliant products are labeled and stored, ready for shipment to hospitals. DONATION The blood collection takes about ten minutes. In addition to the blood bag (450 ml), samples are collected for analysis. SEPARATION OF WHOLE BLOOD The blood is separated into its various components (red blood cells, platelets or plasma). TRANSPORTATION The blood bags and their samples are packed and sent to one of Héma-Québec s laboratories. ANALYSES The blood samples collected during the donation are sent to the qualification laboratory to screen for infections. BLOOD PRODUCTS
10 STABLE PRODUCTS IMPROVING SELF-SUFFIENCY IN PLASMA INTENDED FOR MEDICATION MANUFACTURING Self-sufficiency rate in immunoglobulin relies on the generosity of our donors. SELF-SUFFICIENCY RATE IN IMMUNOGLOBULIN 21.5 % OF IN ,160 LITRES OF PLASMA collected for purposes of manufacturing medications 10
11 MEDICATIONS MANUFACTURED FROM PLASMA EXCLUSIVE DISTRIBUTION for 427,822 Québec STABLE PRODUCTS delivered in Some including 4 50DISTRIBUTED DIFFERENT PRODUCTS MANUFACTURED from plasma collected by Héma-Québec PRODUCTS MANUFACTURED BY PHARMACEUTICAL COMPANIES under agreement with Héma-Québec FROM DONATION TO DISTRIBUTION DELIVERY Products are delivered to hospitals. RETURN OF PRODUCTS TO HÉMA-QUÉBEC AND STORAGE The finished products are then returned to Héma Québec and stored, ready for shipment to hospitals. DONATION Plasma donations are made in donor centres, by appointment. The collection process lasts approximately 45 minutes. FREEZING Plasma is quickly frozen following collection. The faster you freeze it, the more protein you can extract. FRACTIONATION The plasma is sent to fractionation plants. These high-tech plants extract proteins from plasma and use them to make medications. ANALYSES Collections are sent to the qualification laboratory. All donations are tested. STABLE PRODUCTS
12 STEM CELLS STEM CELL DONOR REGISTRY 45,690 registered donors in Québec to meet the needs of patients requiring a stem cell transplant Héma-Québec is a part of a global network that includes 32 MILLION DONORS Rosalie, cord blood recipient 12
13 PUBLIC CORD BLOOD BANK 56 Canada 27 United States 11 England 8 France 2 Italy 2 Turkey 17 Netherlands 1 Austria 1 Israel Internationally recognized expertise 1 Argentina 2 Australia FIRST BANK IN CANADA 9 PARTNER 10,776 HOSPITALS UNITS BANKED 128 UNITS DISTRIBUTED THROUGHOUT THE WORLD SINCE UNITS DISTRIBUTED IN FROM DONATION TO TRANSPLANT DONATION Cord blood is collected at birth in partner hospitals. TRANSPLANT The patient receives the transplant. CALL AND RESEARCH When our registry receives a call, we search for a compatible unit for a patient in need of a stem cell transplant C TRANSPORTATION Cord blood is transported to Héma-Québec. QUALIFICATION Cord blood is qualified based on strict criteria. PROCESSING AND STORAGE Cord blood is processed, frozen at 150 C and stored for 15 years. The units of cord blood are made available through a world registry. STEM CELLS
14 HUMAN TISSUES Claudie-Ann, customer service agent (human tissues), handles musculoskeletal products. 14
15 HUMAN TISSUE BANK Héma-Québec collects the following human tissues: Ocular tissues (corneas, scleras) Heart valves Skin tissues Arterial tissues (abdominal aortas, arteries...) Musculoskeletal tissues (tendons, bone chips, femoral heads...) IN ,451 TISSUES DISTRIBUTED to hospitals 1,008 DONORS WHO DONATED in Québec 5,464 DONOR REFERRALS FROM DONOR REFERRALS TO TRANSPLANT TRANSPLANT The surgeon transplants the tissues. One human tissue donation can help up to 20 people. PROCESSING AND STORAGE The tissues are processed and stored until they are transplanted. Most tissues can be preserved for up to five years, with the exception of corneas that cannot be preserved beyond 14 days. COLLECTION Héma-Québec performs the collection of human tissues. DONOR REFERRALS Health professionals recommend donors to Héma-Québec. CONSENT A verification of the consent registries is made. Whether consent is registered or not, it is important for the donor to inform his or her loved ones if he or she consents to the donation of human tissues, since they will be the ones who will speak on his or her behalf at the time of his or her death. QUALIFICATION Héma-Québec conducts a thorough evaluation to verify the donor s eligibility. HUMAN TISSUES
16 MOTHER S MILK Mévick received mother s milk at birth. 16
17 PUBLIC MOTHERS MILK BANK FOR VERY PRETERM INFANTS IN ,767 BOTTLES DISTRIBUTED 853 REGISTERED DONORS FROM DONATION TO DISTRIBUTION DELIVERY The milk is distributed to hospitals for very premature infants who cannot be breastfed by their mothers. MICROBIOLOGICAL ANALYSES AND STORAGE Héma-Québec tests the milk to ensure that it is safe for recipients; if the results are satisfactory, the milk is frozen and stored for a year. PASTEURIZATION The milk is pasteurized to eliminate viruses and bacteria. DONATION Héma-Québec supplies the bottles; mothers collect their milk at home and freeze it. DONATION POOLING Héma-Québec combines donations from several donors into one batch. PICK-UP AND DROP-OFF POINT Depending on the region, Héma-Québec collects the bottles at the donor s home or the donor brings the milk to a drop-off point. MICROBIOLOGICAL ANALYSES Héma-Québec conducts tests on the unpasteurized milk to ensure that it meets quality standards. MOTHER S MILK
18 SPECIALIZED LABORATORY SERVICES FOR HOSPITALS 4,704 testing requests received from hospitals Complex cases in erythrocyte immunology 1,470 ANALYSES (patients cases) Erythrocyte genotyping of blood groups 3,783 ANALYSES (patients cases and donors) Screening for virological markers 1,715 ANALYSES (donors in hospitals) Phenotypimg 21,114 PHENOTYPED PACKED RED BLOOD CELLS distributed 18
19 CHALLENGE OF DIVERSITY The blood supply and the Stem Cell Donor Registry have to be representative of the makeup of Canada s population. Andy, donor The treatment of certain hereditary blood disorders and stem cell grafts require that the donor and recipient share a similar genetic makeup. Héma-Québec works closely with cultural communities to raise awareness about blood and stem cell donations. Priscille, recipient 12 % of blood donors are of non-caucasian origin This proportion is 15% in the Québec population. 19
20 RISK AND QUALITY MANAGEMENT: A CONSTANT CONCERN 15 PATHOGENS ARE BEING MONITORED: bacteria, viruses or parasites that can be transmitted through blood PREVENTION: AN IMPORTANT ASPECT OF SAFETY SAFETY ADVISORY COMITTEE This comittee encompasses international experts and Canadian Blood Services representative. It monitors all existing and emerging pathogens and makes recommendations to the Board. Donations confirmed positive according to the markers Human immunodeficiency virus (HIV) Hepatitis C virus (HCV) Hepatitis B virus (HBV)* Human T-cell lymphotropic virus (HTLV) Syphilis Total number of donations 277, , , , ,900 *Results related to recent donor immunization are excluded as they are false positives. Héma-Québec makes every effort to provide the Québec population with biological products of human origin that are safe and of optimal-quality. HEALTH CANADA ACCREDITATIONS Blood Regulations BLOOD Safety of Human Cells, Tissues and Organs for Transplantation Regulations STEM CELLS, HUMAN TISSUES ISO Quality management systems providing a framework for the manufacturing of aortic and pulmonary heart valve allografts HUMAN TISSUES ISO Medical biology laboratories and erythrocyte, platelet and HLA analysis laboratories BLOOD, STEM CELLS AATB American Association of Tissue Banks HUMAN TISSUES ASHI American Society for Histocompatibility and Immunogenetics (HLA analysis laboratory) BLOOD, STEM CELLS NetCord-FACT International Standards for Cord Blood Collection, Banking and Release for Administration CORD BLOOD WMDA (qualified member) World Marrow Donor Association STEM CELLS 20
21 STRATEGIC PLAN How does Héma-Québec intend to become a strategic partner of the Québec health system? 6 STRATEGIC ORIENTATIONS 1 By comparing its practices with those of the leaders in its field, and taking the necessary steps to achieve its objectives for the benefit of its partners, and assuming its responsibility for the results 2 By keeping up with the latest developments in human biological products and being proactive so that the healthcare network can benefit from this expertise 3 By managing risks in an integrated manner at all levels of the organization in accordance with best practices 4 By modernizing and streamlining its processes in order to be more effective 5 By taking advantage of digital technology to improve its communication with its partners 6 By developing the skills of its employees and mobilizing them by implementing a talent and succession management program 21
22 BLOOD PRODUCTS STABLE PRODUCTS STEM CELLS HUMAN TISSUES MOTHER S MILK
23 Published by the Direction des relations publiques, Vice-présidence aux relations publiques et au secrétariat général. Data reflects results as at March 31, Reproduction of material contained in this publication is permitted with acknowledgement of its source. Original text in French. In the event of a discrepancy between the English and French versions, the latter will prevail. Legal Deposit Bibliothèques et Archives nationales du Québec, 2018 Library and Archives Canada, 2018 ISSN (printed version) ISSN (online version)
24
BLOOD TRANSFUSIONS. Answers. To Your. Questions
BLOOD TRANSFUSIONS Answers To Your Questions Answers to Your Questions This brochure is intended for people who may need a blood or blood product transfusion and for those who regularly receive transfusions.
More informationBLOOD TRANSFUSIONS. Answers. To Your. Questions
BLOOD TRANSFUSIONS Answers To Your Questions Answers to Your Questions This brochure is intended for people who may need a blood or blood product transfusion and for those who regularly receive transfusions.
More informationAnswers. To Your. Questions
Blood Transfusions Answers To Your Questions Answers to Your Questions This brochure is intended for people who may need a blood or blood product transfusion and for those who regularly receive transfusions.
More informationTransparency, Equity, Ethics: access to care. quality of life. Improving. and patients. An Agency of the French Ministry of Health
An Agency of the French Ministry of Health Transparency, Equity, Ethics: Improving access to care and patients quality of life AgenceBiomedecine_Plaquette_GB.indd 1 25/08/14 12:15 Contents P.1 Agence de
More informationCIRCULAR OF INFORMATION PASTEURIZED HUMAN MILK
CIRCULAR OF INFORMATION PASTEURIZED HUMAN MILK PLEASE READ CAREFULLY 1. General Information This circular supplements the information contained on the labels of bottles of pasteurized human milk. The Public
More informationCoding and Labelling of
Coding and Labelling of Tissues in Europe Deirdre Fehily Why are Tissue Coding and Labelling Important? Anonimity Traceability global uniqueness Standardised product information Potential for electronic
More informationEuropean actions in the field of transplantation & blood transfusion
European actions in the field of transplantation & blood transfusion Andrzej Rys Director Directorate Health Systems and Products Madrid, 27 June 2013 1 Blood Tissues and cells Organs 2 Blood transfusion
More informationTRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES ADVISORY COMMITTEE MEETING October2010. Issue Summary
TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES ADVISORY COMMITTEE MEETING 28-29October2010 Issue Summary Informational Topic: FDA s Geographic Donor Deferral Policy to Reduce the Possible Risk of Transmission
More informationZika Virus. Report to the Standing Committee on Health. Dr. Graham Sher Chief Executive Officer, Canadian Blood Services
Dr. Graham Sher Chief Executive Officer, Services Dr. Dana Devine Chief Medical and Scientific Officer, Services Services Services is an arm s-length organization within the larger health-care system of
More informationD7.1 Report summarising results of survey of EU countries to identify volumes and trends in relation to the import and export of stem cells
Disclaimer: The content of this Deliverable represents the views of the author only and is his/her sole responsibility; it cannot be considered to reflect the views of the European Commission and/or the
More informationD7.1 Report summarising results of survey of EU countries to identify volumes and trends in relation to the import and export of stem cells
Disclaimer: The content of this Deliverable represents the views of the author only and is his/her sole responsibility; it cannot be considered to reflect the views of the European Commission and/or the
More informationBlood Drive Coordinator Handbook.
Blood Drive Coordinator Handbook www.communitybloodservices.org How Blood Donations Help Save Lives... Eleanor Hahn Eleanor Hahn was just 15 when she and her family received startling news: Eleanor had
More informationIntroduction to EU 'SoHO' Sector Screening Meeting with the Republic of Serbia December 5, 2014 Directorate General for Health and Consumers Unit D4
Introduction to EU 'SoHO' Sector Screening Meeting with the Republic of Serbia December 5, 2014 Directorate General for Unit D4 1. Introduction: SoHO & the Legal Basis 2. The Legislative Framework 3. Blood
More informationUsing Donor Human Milk in Extremely Premature Infants
Using Donor Human Milk in Extremely Premature Infants Introduction Scott Eaker, Vice President of Quality and Regulatory Affairs Scott Elster, Chief Executive Officer David Rechtman, MD, Chief Medical
More informationThe establishment of well-organized, nationally-coordinated blood transfusion services with quality systems in all areas
Blood Safety Global Database on Blood Safety (GDBS) 2013 The World Health Organization (WHO) programme on Blood Transfusion Safety would appreciate your kind cooperation in completing this data collection
More informationREPORT CARD on Canada s Blood System
2005-2007 REPORT CRD on Canada s Blood System Ten Years after the Commission of Inquiry on the Blood System in Canada Prepared by the Blood Safety and Supply Committee of the Canadian Hemophilia Society
More informationL 256/32 Official Journal of the European Union
L 256/32 Official Journal of the European Union 1.10.2005 COMMISSION DIRECTIVE 2005/61/EC of 30 September 2005 implementing Directive 2002/98/EC of the European Parliament and of the Council as regards
More informationOrgan and Tissue Donation Emergency Department Orientation. Calgary Health Trust May, 2015
Organ and Tissue Donation Emergency Department Orientation Calgary Health Trust May, 2015 Fact Vs. Fiction 2 Southern Alberta Organ & Tissue Donation Program Southern Alberta Organ Donation Program HOPE
More informationReporting from Council of Europe member states on the collection, testing and use of blood and blood components in Europe The 2006 Survey
Reporting from Council of Europe member states on the collection, testing and use of blood and blood components in Europe The 2006 Survey This questionnaire consists of three sections: A. Collection and
More informationHuman tissues and cells annual report 2011
Human tissues and cells annual report 2011 2012 Human tissues and cells Annual report Danish Health and Medicines Authority, 2012. This publication can be freely cited with a clear indication of source.
More informationVersatile grafting Solutions
Versatile grafting Solutions A Canadian company serving Canadian dentists since 1997 Here s why your colleagues are calling us for their bone regeneration needs Founded in 1997 Citagenix has been providing
More informationNATIONAL BLOOD TRANSFUSION SERVICES STRATEGY
FEDERAL DEMOCRATIC REPUBLIC OF ETHIOPIA MINISTRY OF HEALTH NATIONAL BLOOD TRANSFUSION SERVICES STRATEGY February 2005 Addis Ababa Ethiopia Acknowledgement The Ministry of Health of the Federal Democratic
More informationNATIONAL MARROW DONOR PROGRAM. Creating Connections. Saving Lives. Fran Rabe
Creating Connections. Saving Lives. National Marrow Donor Program (NMDP) Screening of International Donors Fran Rabe FDA Liaison Meeting January 4, 2007 U.S. Importation of Peripheral Blood Stem Cells
More informationNHSBT Board July Update on UK Living Kidney Sharing Scheme
1. Status Public 2. Executive Summary NHSBT Board July 27 2017 Update on UK Living Kidney Sharing Scheme This paper provides an update on activity and plans for the UK Living Kidney Sharing Scheme (UKLKSS),
More information15. Procuring, processing and transporting gametes and
15. Procuring, processing and transporting gametes and embryos Version 6.0 On this page: : Extracts from the HFE Act Directions HFEA guidance: Documented procedures: general Patient selection and procurement
More informationOPERATIONS AND PATIENT SERVICES USER GUIDE. Procedures for transplant centres and international establishments
OPERATIONS AND PATIENT SERVICES USER GUIDE Procedures for transplant centres and international establishments 1. INTRODUCTION 9 1.1. Introduction 9 1.2. User Guide 9 1.3. Services Provided by Anthony Nolan
More informationFact Sheet Blood Collection and Use Hong Kong Red Cross Blood Transfusion Service The Hong Kong Red Cross began its voluntary, nonremunerated blood donation programme to supply blood to all hospitals in
More informationPaired Organ Exchange: Ethical Considerations Regarding a New Option
2006 SUPPLEMENT To the position statement Organ Donation and Transplantation: Ethical Dilemmas Due to Shortage Paired Organ Exchange: Ethical Considerations Regarding a New Option Summary and recommendations
More informationHEALTH SCREENING QUESTIONNAIRE. Work-up. Donor ID EdgeCell #:
HEALTH SCREENING QUESTIONNAIRE Héma-Québec Registre des Donneurs de Cellules Souches 4045 Côte-vertu, St-Laurent, QC, Canada, H4R 2W7 Tél : + 514-832-1031 Fax : + 514-832-0266 www.hema-quebec.qc.ca CT
More informationBLOOD DONATION AFTER ACUPUNCTURE: A JUSTIFIED DEFERRAL?
BLOOD DONATION AFTER ACUPUNCTURE: A JUSTIFIED DEFERRAL? What if your patients want to donate blood? Are you aware that patients undergoing Acupuncture treatment, according to international guidelines,
More informationMake a difference! Your guide to saving lives through blood donation
Make a difference! Your guide to saving lives through blood donation You have the power to change lives Every two seconds someone needs blood. Accidents happen 24/7, putting family, friends, and neighbors
More informationA guide for families deciding on organ, eye and tissue donation. When your loved one dies
A guide for families deciding on organ, eye and tissue donation When your loved one dies Benefits of Donation Donation may help you with your loss. Organ and tissue donation is a unique opportunity to
More informationHEALTH SCREENING QUESTIONNAIRE CT Work-up. Donor ID EdgeCell #:
HEALTH SCREENING QUESTIONNAIRE CT Work-up Héma-Québec Registre des Donneurs de Cellules Souches 4045 Côte-vertu, St-Laurent, QC, Canada, H4R 2W7 Tél : + 514-832-1031 Fax : + 514-832-0266 www.hema-quebec.qc.ca
More informationOrgan and Tissue Donation
Patient & Family Guide 2017 Organ and Tissue Donation www.nshealth.ca Organ and Tissue Donation Health care providers want to be sure that families of all patients who may be eligible are offered the option
More information2.0 MINIMUM PROCUREMENT STANDARDS FOR AN ORGAN PROCUREMENT ORGANIZATION (OPO)
2.0 MINIMUM PROCUREMENT STANDARDS FOR AN ORGAN PROCUREMENT ORGANIZATION (OPO) In order to maximize the gift of donation and optimize recipient outcomes and safety, the Organ Procurement Organization (OPO)
More informationBackground Paper for the OTDT Committees
Background Paper for the OTDT Committees Organs and Tissues Donation and Transplantation (OTDT) Listing of Key Government Reports Contents 1. Introduction... 2 A. Background... 2 2. Public Recommendation
More informationNational Screening laboratory Sanquin The use of NAT in blood donation screening in The Netherlands. TransMed conference Bhopal 18 November 2016
Dr. Anton van Weert National Screening laboratory Sanquin The use of NAT in blood donation screening in The Netherlands TransMed conference Bhopal 18 Introduction Thank you! Anton van Weert, PhD, MBA Manager
More informationInstructions for Use. Wright Medical Technology 1023 Cherry Road Memphis, TN USA
Instructions for Use Wright Medical Technology 1023 Cherry Road Memphis, TN 38117 USA 1-800-238-7117 Processed from Donated Human Tissue for Wright Medical Technology by LifeCell Corporation One Millennium
More informationAbout OMICS Group Conferences
About OMICS Group OMICS Group International is an amalgamation of Open Access publications and worldwide international science conferences and events. Established in the year 2007 with the sole aim of
More informationOneMatch Stem Cell and Marrow Network. Training Guide
OneMatch Stem Cell and Marrow Network Training Guide What is OneMatch all about? OneMatch is a Canadian Program that matches and coordinates the collection of stem cells from potential donors to help save
More informationPerspectives on self-sufficiency of blood-derived therapies. Global evolution and realities. Albert Farrugia
TERZO INCONTRO NAZIONALE DEL SISTEMA SANGUE ITALIANO I confini dell autosufficienza. Etica, economia, responsabilità. Perspectives on self-sufficiency of blood-derived therapies. Global evolution and realities.
More informationAlamo Tissue Service
Providing Life Enhancing Donor Tissue San Antonio, TX 78249 Toll free 800.226 9091 or 210.738.2663 www.alamotissueservice.com A) T) S) A Tissue Distribution Network Life Enhancing Donor Tissue To Our
More informationThe TTSN - A Collaborative Biovigilance System
The TTSN - A Collaborative Biovigilance System 5th World Congress on Tissue Banking 12th International Conference of the APASTB Kuala Lumpur, Malaysia June 4, 2008 Scott A. Brubaker, CTBS American Association
More informationPlasma for fractionation: South African Plasma Requirements
Plasma for fractionation: South African Plasma Requirements Dr Jeh-han Omarjee Head: Microbiological Sciences NBI is a "not for profit" company committed to providing safe, cost effective, quality medicinal
More information23 November Division of Dockets Management (HFA 305) Food and Drug Administration 5630 Fishers Lane, Rm Rockville, MD 20852
23 November 2016 Division of Dockets Management (HFA 305) Food and Drug Administration 5630 Fishers Lane, Rm. 1061 Rockville, MD 20852 Submitted via http://www.regulations.gov Re: Docket No. FDA-2016-N-1502,
More informationHUNGARIAN NATIONAL BLOOD TRANSFUSION SERVICE. Dr. Klara Baroti-Tóth, PhD IPFA/PEI 19 th International Workshop Budapest, May, 2012.
HUNGARIAN NATIONAL BLOOD TRANSFUSION SERVICE Dr. Klara Baroti-Tóth, PhD IPFA/PEI 19 th International Workshop Budapest, 23-24 May, 212. BLOOD DONATION G I V I N G I S G O O D ORGAN COORDINATION OFFICE
More informationDocumentation of Changes to EFI Standards: v 5.6.1
Modified Standard B - PERSONNEL QUALIFICATIONS B1.000 The laboratory must employ one or more individuals who meet the qualifications and fulfil the responsibilities of the Director/Co-Director, Technical
More informationMore Fun Than Giving Blood CLINIC RECRUITED
More Fun Than Giving Blood CLINIC RECRUITED Are you thinking of becoming a sperm donor? Choosing to become a sperm donor is a generous act, and by entering our sperm donor program you can help make someone
More informationConsent to Shipment of Frozen Embryos to and Short Term Storage of Frozen Embryos at the Family Fertility Center
1. Background On or about and requested clinic and treating physician) at (date), name(s) of parties underwent IVF treatment) (name of (address of clinic) to perform in vitro fertilization using: a. Oocyte
More informationThe Company. Beyond Pioneering
The Company Beyond Pioneering Standardisation Bedrocan is the world s most experienced producer of legal medicinal cannabis. We are currently the only company producing medicinal cannabis flos to good
More informationObjectives. Methods. Results. Economic
Octaplas Compared with Fresh Frozen Plasma to Reduce the Risk of Transmitting Lipid-Enveloped Viruses: An Economic Analysis and Budget Impact Analysis [Adapted from Membe SK, Coyle D, Husereau D, Cimon
More informationTRANSFUSION ASSOCIATED DISEASE, RECALL, OR COMPLICATION INVESTIGATION POLICY I. FATALITIES AND COMPLICATIONS ASSOCIATED WITH TRANSFUSION:
I. FATALITIES AND COMPLICATIONS ASSOCIATED WITH TRANSFUSION: A. TRANSFUSION RELATED FATALITY: FDA and MEDIC must be notified immediately, and subsequently in writing, when a possible transfusion related
More informationTHE BUILDING BLOCKS OF BONE FUSION. Medline Demineralized Bone Allografts Safe and Effective Grafting Options
THE BUILDING BLOCKS OF BONE FUSION. Medline Demineralized Bone Allografts Safe and Effective Grafting Options 2 MEDLINE BUILD ON QUALITY. Successful bone fusion and osteogenesis depend on a number of factors
More informationBMTCN REVIEW COURSE PRE-TRANSPLANT CARE
BMTCN REVIEW COURSE PRE-TRANSPLANT CARE Jennifer Shamai MS, RN, AOCNS, BMTCN Professional Practice Leader Department of Clinical Practice And Professional Education Click How to edit the Master Experts
More informationGuidelines for Gamma Irradiation of Blood Components
AUSTRALIAN & NEW ZEALAND SOCIETY OF BLOOD TRANSFUSION INC. AUSTRALIAN RED CROSS BLOOD SERVICE NEW ZEALAND BLOOD SERVICE Guidelines for Gamma Irradiation of Blood Components Revised 2003 AN ZS B T Australian
More informationGuide to the preparation, use and quality assurance of blood components
Contents Foreword...3 Members of the European Committee (Partial Agreement) on Blood Transfusion... 8 Members of the GTS working group... 22 Members of the TS066 working group... 30 Recommendation No.
More informationUnited Kingdom National External Quality Assessment Service for Microbiology [Established 1971]
United Kingdom National External Quality Assessment Service for Microbiology [Established 97] UK NEQAS covers Andrology Chemistry Genetics Haematology Histopathology Immunology Leucocyte Immunophenotyping
More informationMSM DEFERRAL POLICY ISSUE DOCUMENT: MSM DEFERRAL ISSUE BACKGROUND
MSM DEFERRAL POLICY ISSUE DOCUMENT: MSM DEFERRAL ISSUE Countries around the world are reviewing the policy of deferring from blood donation men who have had sex with men (MSM). Both Canadian Blood Services
More informationCord Blood Bankers are. Angie Yost, MT(ASCP) CM 2016 ASCLS-MO CLMA Spring Meeting
Cord Blood Bankers are Angie Yost, MT(ASCP) CM 2016 ASCLS-MO CLMA Spring Meeting Objectives Cord blood 101 Manufacturing and cryopreservation Characterization testing Why Do We Need Cord Blood? Each year,
More informationT-PLIF Spacer. An allograft spacer for transforaminal posterior lumbar interbody fusion.
Processed by MTF, designed and available through.. An allograft spacer for transforaminal posterior lumbar interbody fusion. The has been engineered to meet the specific demands of transforaminal posterior
More information2015-Activities, Tissue Types and Inspections
2015-Activities, Tissue Types and Inspections Form Approved OMB No. 0990-0457 Exp. Date 06/30/2020 Welcome to the 2015 Activities Tissue Types and Inspections survey. Please refer to the following instructions
More informationProduct Insert ProKera is approved by the US FDA (510K Approval) as a class II medical device.
Product Insert ProKera is approved by the US FDA (510K Approval) as a class II medical device. Effective Date: 2/23/2005 Version 1 ProKera is a corneal-epithelial device consisting of an ophthalmic conformer
More information41st DIRECTING COUNCIL
PAN AMERICAN HEALTH ORGANIZATION WORLD HEALTH ORGANIZATION 41st DIRECTING COUNCIL San Juan, Puerto Rico, 27 September-1 October 1999 Provisional Agenda Item 4.8 CD41/13 (Eng.) 19 July 1999 ORIGINAL: ENGLISH
More informationReport on the Transplantation Transmission Sentinel Network (TTSN)
Report on the Transplantation Transmission Sentinel Network (TTSN) CATB Session - AATB s 31st Annual Meeting, Boston September 15, 2007 Scott Brubaker, CTBS AATB Representative, TTSN Advisory Group TTSN
More informationLEGISLATIVE FRAMEWORKS AND ETHICS OF DONATION. Jeff Szer, Royal Melbourne Hospital, Australia
LEGISLATIVE FRAMEWORKS AND ETHICS OF DONATION Jeff Szer, Royal Melbourne Hospital, Australia Donation of HPC Autologous HPC-A HPC-M Allogeneic Family member Volunteer Unrelated HPC-A HPC-M HPC-C Ethical
More informationChapter 10. Histocompatibility Testing
Chapter 10 Histocompatibility Testing Change record Date Author Version Change reference 08-03-2013 J. de Boer 2.0 Textual Adjustments 13-09-2012 C.M. Tieken 1.1 Text added page 2 10-03-2012 I. Doxiadis
More information[Type here] Version Approval Dates Announcement Date Effective Standards Committee: Jan 2019
SECTION D AUTHORIZATION, INFORMED CONSENT, DONOR SCREENING, AND TISSUE RECOVERY, COLLECTION, AND ACQUISITION D1.000 GENERAL POLICIES In addition to the requirements at the series of standards at B1.500,
More informationTitle: SECTION 7.0 NZBMDR STANDARDS PROCESS FOR DONOR IDENTIFICATION
Title: SECTION 7.0 NZBMDR STANDARDS PROCESS FOR DONOR IDENTIFICATION Authorised by: Executive Officer Contributing Authors: ABMDR Scientific Expert Advisory Committee Sally Gordon Dr Hilary Blacklock Raewyn
More informationThe Organ and Tissue Donor Program
The Organ and Tissue Donor Program If I needed a kidney or some other vital organ to live Would I be able to get one? Maybe. Many people who need organ transplants cannot get them because of a shortage
More informationNDRI Private Donor Program: Accelerating Biomedical Research via Private Donation
1 NDRI Private Donor Program: Accelerating Biomedical Research via Private Donation Jeffrey Thomas Vice President, Strategic Initiatives Honesto Nunez III Private Donor/Rare Disease Manager Webinar Objectives
More informationProducts and Services Catalogue
Products and Services Catalogue Solid and Flexible Bio-Processed Allograft Implants Advancing Tissue Innovations Since 1972 Updated June 2011 A History of Providing Highest Quality and Innovation Mount
More informationSurveillance Report 2015
Surveillance Report 2015 Executive summary We are pleased to present the fourth report for our stakeholders describing infectious disease surveillance. High quality and timely surveillance is key to the
More informationBONE VOID FILLERS CONTAINING DONATED HUMAN TISSUE The following languages are included in this packet:
BONE VOID FILLERS CONTAINING DONATED HUMAN TISSUE 150815-0 The following languages are included in this packet: English (en) Deutsch (de) Nederlands (nl) Français (fr) Español (es) Italiano (it) Português
More informationBecause you care about CONSUMERS HEALTH
Because you care about CONSUMERS HEALTH PROFILE PUBLIC HEALTH Today, as new food and water-related risks continue to emerge, and at a time when the relationships between infectious diseases, cancer and
More informationOverview of Blood Transfusion System of Iran:
Report Article Overview of Blood Transfusion System of Iran: 2002-2011 AM Cheraghali High Institute for Research and Education on Transfusion Medicine, Iran Blood Transfusion Organization and University
More informationSperm donation Oocyte donation. Hong Kong þ Guideline þ þ Hungary þ þ þ þ Israel þ þ þ þ Italy þ þ þ. Germany þ þ þ þ Greece þ þ þ þ
CHAPTER 8: Donation Although there has been a reduction in the use of donor sperm because of ICSI and the impact of the removal of anonymity in some countries (1), sperm donation is still used and has
More informationLeading Australia towards the elimination of viral hepatitis
Leading Australia towards the elimination of viral hepatitis Australian Federal Election 2016 About Hepatitis Australia Our vision is an end to hepatitis B and hepatitis C in Australia. Our mission is
More informationDuration: 12 months May to April
SPECIALIST CERTIFICATE IN TRANSFUSION SCIENCE PRACTICE PROGRAMME OF STUDY OVERVIEW Example only Duration: 12 months May to April This document serves as a general programme overview only. To ensure you
More informationDemand for Ocular Tissue in Canada - Final Report
Demand for Ocular Tissue in Canada - Final Report January 2010 Table of Contents Executive Summary... 3 Background... 4 Purpose... 4 Overview... 4 Limitations... 4 Waiting Lists for Cornea Transplants...
More informationDEFINITIONS OF HISTOCOMPATIBILITY TYPING TERMS
DEFINITIONS OF HISTOCOMPATIBILITY TYPING TERMS The definitions below are intended as general concepts. There will be exceptions to these general definitions. These definitions do not imply any specific
More informationStorage of sperm prior to treatment for cancer
Patient information leaflet Royal Surrey County Hospital NHS Foundation Trust Storage of sperm prior to treatment for cancer Cytology Cancer and fertility: a guide for men This leaflet is aimed at men
More informationAn introduction to organ and tissue donation
Student resource Lesson 1: An introduction to organ and tissue donation Lesson outcomes To be able to give a definition of organ and tissue donation, a transplant, a recipient and the NHS Organ Donor Register
More informationHuman Zoster Immunoglobulin, solution for intramuscular injection.
Product Information Zoster Immunoglobulin-VF Australia NAME OF THE MEDICINE Human Zoster Immunoglobulin, solution for intramuscular injection. DESCRIPTION Zoster Immunoglobulin-VF is a sterile, preservative-free
More informationOrgan Procurement and Transplantation Network
OPTN Organ Procurement and Transplantation Network POLICIES This document provides the policy language approved by the OPTN/UNOS Board at its meeting in June 2015 as part of the Operations and Safety Committee
More informationFinancial Resources for HIV: PEPFAR s Contributions to the Global Scale-up of Treatment
Financial Resources for HIV: PEPFAR s Contributions to the Global Scale-up of Treatment Joint WHO & UNAIDS Consultation with Pharmaceuticals and Stakeholders November 05 2012 Lara Stabinski, MD, MPH Medical
More informationSummary of Key Points. WHO Position Paper on Vaccines against Hepatitis B, July 2017
Summary of Key Points WHO Position Paper on Vaccines against Hepatitis B, July 2017 1 Background l HBV is transmitted by exposure of mucosal membranes or non-intact skin to infected blood, saliva, semen
More information2009 Eye Banking Statistical Report Eye Bank Association of America th Street, N.W. Suite 1010 Washington, DC Phone (202) Fax
2009 Eye Banking Statistical Report Eye Bank Association of America 1015 18th Street, N.W. Suite 1010 Washington, DC 20036 Phone (202) 775-4999 Fax (202) 429-6036 www.restoresight.org Introduction 2009
More informationEZER MIZION PROCEDURES FOR TRANSPLANT CENTERS AND COOPERATIVE REGISTRIES
EZER MIZION PROCEDURES FOR TRANSPLANT CENTERS AND COOPERATIVE REGISTRIES Table of content 1. Purpose and Scope... 2 2. Introduction... 2 3. Procedure for Requesting a Search... 3 4. The Search Process...
More informationUnderstanding Blood Transfusion and The Zimmer OrthoPAT * System
Understanding Blood Transfusion and The Zimmer OrthoPAT * System Know Your Options A global leader in the provision of high-quality, hands-on education and training for orthopaedic surgeons. *Trademark
More informationWHAT IS A PATIENT CARE ADVOCATE?
WHAT IS A PATIENT CARE ADVOCATE? Fertility treatments can be overwhelming. As a member, you have unlimited access to a dedicated Patient Care Advocate (PCA), who acts as your expert resource for discussing
More informationTransfusion-transmitted Cytomegalovirus
Transfusion-transmitted Cytomegalovirus Can you confidently abandon CMV seronegative products in the modern era of pre-storage leukoreduction? Jeannie Callum, BA, MD, FRCPC Really? Are we still talking
More informationDatabase on Blood Safety 2009 in ECO Member States
Database on Blood Safety 2009 in ECO Member States Section 1: Administrative Information Information provided by: 1.1 Name: 1.2 Title: 1.3 Position: 1.4 Organization: 1.5 Address: 1.6 Country: 1.7 Tel.
More informationBreastfeeding Center Milk Connection Questionnaire and Release for Donor
Breastfeeding Center Milk Connection Questionnaire and Release for Donor All of us at The Breastfeeding Center are deeply grateful to you for your important gift to infants in our community. Your donated
More informationHot Topics in Tissue Safety
Hot Topics in Tissue Safety 37 th Annual AATB Meeting National Harbor, Maryland 03 October 2013 Scott A. Brubaker, CTBS Chief Policy Officer PHS Guideline for Reducing Human Immunodeficiency Virus, Hepatitis
More informationTuberous Sclerosis Australia Strategic Plan
Tuberous Sclerosis Australia Strategic Plan Last updated 27 November 2017 1. Our vision for the lives of people affected by tuberous sclerosis (TSC) 1. The impact of a diagnosis of TSC Tuberous Sclerosis
More informationBetter Partner Health
4 Better Partner Health Building strategic partnerships with like-minded organizations, companies and government bodies better positions Mylan to reach patients and achieve our mission. From R&D to manufacturing
More informationHow to give life? Organ donation, Let's talk about it! With the EDQM, Council of Europe. European Day for Organ Donation and transplantation (EODD)
How to give life? Organ donation, Let's talk about it! With the EDQM, Council of Europe European Day for Organ Donation and transplantation (EODD) Organ donation How does the Council of Europe contribute?
More informationA guide for families deciding on organ, eye and tissue donation. When your loved one dies
A guide for families deciding on organ, eye and tissue donation When your loved one dies 2 Benefits of Donation Donation may help you with your loss. Organ and tissue donation is a unique opportunity to
More informationBloodborne Pathogens and Exposure Control
Bloodborne Pathogens and Exposure Control 2016 Information in the Exposure Control Plan The Bloodborne Pathogen Exposure Control Plan was developed to communicate information to you about: - Your risk
More informationTGA regulation of local manufacturers of plasma derivatives CSL Behring Australia s overview
IPFA Workshop Session 7: REGULATORY CONSIDERATIONS TGA regulation of local manufacturers of plasma derivatives CSL Behring Australia s overview Mary Lavithis, CSL Behring Australia Presented at: IPFA Asia
More information